1. Home
  2. RNXT vs SPCB Comparison

RNXT vs SPCB Comparison

Compare RNXT & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • SPCB
  • Stock Information
  • Founded
  • RNXT 2012
  • SPCB 1988
  • Country
  • RNXT United States
  • SPCB Israel
  • Employees
  • RNXT N/A
  • SPCB N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • SPCB Semiconductors
  • Sector
  • RNXT Health Care
  • SPCB Technology
  • Exchange
  • RNXT Nasdaq
  • SPCB Nasdaq
  • Market Cap
  • RNXT 44.6M
  • SPCB 53.3M
  • IPO Year
  • RNXT 2021
  • SPCB N/A
  • Fundamental
  • Price
  • RNXT $1.40
  • SPCB $9.83
  • Analyst Decision
  • RNXT Strong Buy
  • SPCB Strong Buy
  • Analyst Count
  • RNXT 2
  • SPCB 1
  • Target Price
  • RNXT $7.25
  • SPCB $18.00
  • AVG Volume (30 Days)
  • RNXT 142.5K
  • SPCB 133.1K
  • Earning Date
  • RNXT 08-14-2025
  • SPCB 08-14-2025
  • Dividend Yield
  • RNXT N/A
  • SPCB N/A
  • EPS Growth
  • RNXT N/A
  • SPCB N/A
  • EPS
  • RNXT N/A
  • SPCB 1.89
  • Revenue
  • RNXT $240,000.00
  • SPCB $27,831,000.00
  • Revenue This Year
  • RNXT $3,104.65
  • SPCB $2.73
  • Revenue Next Year
  • RNXT $301.89
  • SPCB $22.87
  • P/E Ratio
  • RNXT N/A
  • SPCB $5.56
  • Revenue Growth
  • RNXT N/A
  • SPCB 2.90
  • 52 Week Low
  • RNXT $0.75
  • SPCB $2.55
  • 52 Week High
  • RNXT $1.69
  • SPCB $18.95
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 58.26
  • SPCB 47.27
  • Support Level
  • RNXT $1.28
  • SPCB $9.23
  • Resistance Level
  • RNXT $1.37
  • SPCB $11.00
  • Average True Range (ATR)
  • RNXT 0.07
  • SPCB 0.63
  • MACD
  • RNXT -0.01
  • SPCB -0.11
  • Stochastic Oscillator
  • RNXT 87.10
  • SPCB 31.41

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

Share on Social Networks: